Form 4: West Pharmaceutical Services CEO Exercises Stock Options and Sells Shares

Eric Mark Green, President, CEO, and Board Chair of West Pharmaceutical Services, executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On August 6, 2024, Eric Mark Green, the President, CEO, and Board Chair of West Pharmaceutical Services, exercised stock options to acquire 36,732 shares of common stock at a price of $59.64 per share.
• Simultaneously, Green sold 30,732 shares of common stock at a weighted average price of $304.712 per share.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 17, 2023.
• Following these transactions, Green directly owns 167,898.1245 shares of West Pharmaceutical Services common stock and 0 derivative securities.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

Executive stock option exercises and sales are common and often pre-planned to diversify personal holdings and manage tax liabilities. The use of a 10b5-1 plan suggests the transactions were planned well in advance to avoid any appearance of trading on inside information.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increased supply of shares in the market, but the pre-planned nature of the sale mitigates concerns about insider information.

Key Dates